Cargando…
Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey
Background: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging. Devices and tools are rapidly evolving. We aimed to gain insight into preferences and global perspectives on the usage of endovascular tools in treating MeVOs. Methods: We conduc...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480153/ https://www.ncbi.nlm.nih.gov/pubmed/34603187 http://dx.doi.org/10.3389/fneur.2021.735899 |
_version_ | 1784576416016236544 |
---|---|
author | Kashani, Nima Cimflova, Petra Ospel, Johanna M. Singh, Nishita Almekhlafi, Mohammed A. Rempel, Jeremy Fiehler, Jens Chen, Michael Sakai, Nobuyuki Agid, Ronit Heran, Manraj Kappelhof, Manon Goyal, Mayank |
author_facet | Kashani, Nima Cimflova, Petra Ospel, Johanna M. Singh, Nishita Almekhlafi, Mohammed A. Rempel, Jeremy Fiehler, Jens Chen, Michael Sakai, Nobuyuki Agid, Ronit Heran, Manraj Kappelhof, Manon Goyal, Mayank |
author_sort | Kashani, Nima |
collection | PubMed |
description | Background: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging. Devices and tools are rapidly evolving. We aimed to gain insight into preferences and global perspectives on the usage of endovascular tools in treating MeVOs. Methods: We conducted an international survey with seven scenarios of patients presenting A3, M2/3, M3, M3/4, or P2/3 occlusions. Respondents were asked for their preferred first-line endovascular approach, and whether they felt that the appropriate endovascular tools were available to them. Answers were analyzed by occlusion location and geographical region of practice, using multinomial/binary logistic regression. Results: A total of 263 neurointerventionists provided 1836 responses. The first-line preferences of physicians were evenly distributed among stent-retrievers, combined approaches, and aspiration only (33.2, 29.8, and 26.8%, respectively). A3 occlusions were more often treated with stent-retrievers (RR 1.21, 95% CI: 1.07–1.36), while intra-arterial thrombolysis was more often preferred in M3 (RR 2.47, 95% CI: 1.53–3.98) and M3/4 occlusions (RR 7.71, 95% CI: 4.16–14.28) compared to M2/3 occlusions. Respondents who thought appropriate tools are currently not available more often chose stent retrievers alone (RR 2.07; 95% CI: 1.01–4.24) or intra-arterial thrombolysis (RR 3.35, 95% CI: 1.26–8.42). Physicians who stated that they do not have access to optimal tools opted more often not to treat at all (RR 3.41, 95% CI: 1.11–10.49). Stent-retrievers alone were chosen more often and contact aspiration alone less often as a first-line approach in Europe (RR 2.12, 95% CI: 1.38–3.24; and RR 0.49, 95% CI 0.34–0.70, respectively) compared to the United States and Canada. Conclusions: In EVT for MeVO strokes, neurointerventionalists choose a targeted vessel specific first-line approach depending on the occlusion location, region of practice, and availability of the appropriate tools. |
format | Online Article Text |
id | pubmed-8480153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84801532021-09-30 Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey Kashani, Nima Cimflova, Petra Ospel, Johanna M. Singh, Nishita Almekhlafi, Mohammed A. Rempel, Jeremy Fiehler, Jens Chen, Michael Sakai, Nobuyuki Agid, Ronit Heran, Manraj Kappelhof, Manon Goyal, Mayank Front Neurol Neurology Background: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging. Devices and tools are rapidly evolving. We aimed to gain insight into preferences and global perspectives on the usage of endovascular tools in treating MeVOs. Methods: We conducted an international survey with seven scenarios of patients presenting A3, M2/3, M3, M3/4, or P2/3 occlusions. Respondents were asked for their preferred first-line endovascular approach, and whether they felt that the appropriate endovascular tools were available to them. Answers were analyzed by occlusion location and geographical region of practice, using multinomial/binary logistic regression. Results: A total of 263 neurointerventionists provided 1836 responses. The first-line preferences of physicians were evenly distributed among stent-retrievers, combined approaches, and aspiration only (33.2, 29.8, and 26.8%, respectively). A3 occlusions were more often treated with stent-retrievers (RR 1.21, 95% CI: 1.07–1.36), while intra-arterial thrombolysis was more often preferred in M3 (RR 2.47, 95% CI: 1.53–3.98) and M3/4 occlusions (RR 7.71, 95% CI: 4.16–14.28) compared to M2/3 occlusions. Respondents who thought appropriate tools are currently not available more often chose stent retrievers alone (RR 2.07; 95% CI: 1.01–4.24) or intra-arterial thrombolysis (RR 3.35, 95% CI: 1.26–8.42). Physicians who stated that they do not have access to optimal tools opted more often not to treat at all (RR 3.41, 95% CI: 1.11–10.49). Stent-retrievers alone were chosen more often and contact aspiration alone less often as a first-line approach in Europe (RR 2.12, 95% CI: 1.38–3.24; and RR 0.49, 95% CI 0.34–0.70, respectively) compared to the United States and Canada. Conclusions: In EVT for MeVO strokes, neurointerventionalists choose a targeted vessel specific first-line approach depending on the occlusion location, region of practice, and availability of the appropriate tools. Frontiers Media S.A. 2021-09-15 /pmc/articles/PMC8480153/ /pubmed/34603187 http://dx.doi.org/10.3389/fneur.2021.735899 Text en Copyright © 2021 Kashani, Cimflova, Ospel, Singh, Almekhlafi, Rempel, Fiehler, Chen, Sakai, Agid, Heran, Kappelhof and Goyal. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Kashani, Nima Cimflova, Petra Ospel, Johanna M. Singh, Nishita Almekhlafi, Mohammed A. Rempel, Jeremy Fiehler, Jens Chen, Michael Sakai, Nobuyuki Agid, Ronit Heran, Manraj Kappelhof, Manon Goyal, Mayank Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey |
title | Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey |
title_full | Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey |
title_fullStr | Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey |
title_full_unstemmed | Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey |
title_short | Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey |
title_sort | endovascular device choice and tools for recanalization of medium vessel occlusions: insights from the mevo frontiers international survey |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480153/ https://www.ncbi.nlm.nih.gov/pubmed/34603187 http://dx.doi.org/10.3389/fneur.2021.735899 |
work_keys_str_mv | AT kashaninima endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT cimflovapetra endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT ospeljohannam endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT singhnishita endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT almekhlafimohammeda endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT rempeljeremy endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT fiehlerjens endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT chenmichael endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT sakainobuyuki endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT agidronit endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT heranmanraj endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT kappelhofmanon endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey AT goyalmayank endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey |